Cargando…
Keep out! SARS-CoV-2 entry inhibitors: their role and utility as COVID-19 therapeutics
The COVID-19 pandemic has put healthcare infrastructures and our social and economic lives under unprecedented strain. Effective solutions are needed to end the pandemic while significantly lessening its further impact on mortality and social and economic life. Effective and widely-available vaccine...
Autores principales: | Chitsike, Lennox, Duerksen-Hughes, Penelope |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8301738/ https://www.ncbi.nlm.nih.gov/pubmed/34301275 http://dx.doi.org/10.1186/s12985-021-01624-x |
Ejemplares similares
-
PPI Modulators of E6 as Potential Targeted Therapeutics for Cervical Cancer: Progress and Challenges in Targeting E6
por: Chitsike, Lennox, et al.
Publicado: (2021) -
ACE2 : S1 RBD Interaction-Targeted Peptides and Small Molecules as Potential COVID-19 Therapeutics
por: Chitsike, Lennox, et al.
Publicado: (2021) -
Targeted Therapy as a Potential De-Escalation Strategy in Locally Advanced HPV-Associated Oropharyngeal Cancer: A Literature Review
por: Chitsike, Lennox, et al.
Publicado: (2021) -
A high-content AlphaScreen™ identifies E6-specific small molecule inhibitors as potential therapeutics for HPV(+) head and neck squamous cell carcinomas
por: Chitsike, Lennox, et al.
Publicado: (2021) -
GA-OH enhances the cytotoxicity of photon and proton radiation in HPV(+) HNSCC cells
por: Chitsike, Lennox, et al.
Publicado: (2023)